How many insider declarations has Kenney Christopher John filed?

Kenney Christopher John has filed 4 public insider declarations with SEC (Form 4).

What is Kenney Christopher John's role?

Kenney Christopher John's reported role is not specified by the regulator across the filings.

Which companies does Kenney Christopher John report trades for?

Kenney Christopher John reports trades for 2 companies, including Xenon Pharmaceuticals Inc..

What is Kenney Christopher John's declared buy vs sell volume?

Across the available history, declared buys total 18k€ and disposals 23k€.

← Executives ★ Sign in to follow

KC

Kenney Christopher John

Other

·SEC (Form 4)

Xenon Pharmaceuticals Inc.Xenon Pharmaceuticals Inc.

0

申报总数

0

公司

€17,825

▲ 买入（1 笔）

€22,618

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

1

T+90 胜率

0%

T+90 平均收益

-16.9%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Browse the complete record of transactions filed by Kenney Christopher John. Insider active across 2 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 4 filings have been logged. Split: 1 buy · 1 sell. Total volume traded: €40k. Activity tracked since 21 January 2022. The latest transaction was filed on 24 March 2023 (Cession). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Kenney Christopher John

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Xenon Pharmaceuticals Inc. (US)Xenon Pharmaceuticals Inc. (US)

申报4 总计

◇

KENNEY CHRISTOPHER JOHN

Chief Medical Officer高管2026年3月12日Xenon Pharmaceuticals Inc.

0SEC ↗

3,750 股Common SharesSEC:0001193125-26-106727:0

◇

KENNEY CHRISTOPHER JOHN

Chief Medical Officer高管2026年3月9日Xenon Pharmaceuticals Inc.

0SEC ↗

7,500 股Common SharesSEC:0001193125-26-102669:0

▼

KENNEY CHRISTOPHER JOHN

Chief Medical Officer高管2023年3月24日Xenon Pharmaceuticals Inc.

US$24,50730SEC ↗

700 股@ US$35.01100.0% 占其流量Common SharesSEC:0001209191-23-021136:0

▲

KENNEY CHRISTOPHER JOHN

Chief Medical Officer高管2022年1月21日Xenon Pharmaceuticals Inc.

US$20,16723SEC ↗

700 股@ US$28.81100.0% 占其流量Common SharesSEC:0001209191-22-004460:0

标准退出：2022年4月21日 (T+90)

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

KC

Kenney Christopher John

Other

·SEC (Form 4)

Xenon Pharmaceuticals Inc.Xenon Pharmaceuticals Inc.

0

申报总数

0

公司

€17,825

▲ 买入（1 笔）

€22,618

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

1

T+90 胜率

0%

T+90 平均收益

-16.9%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Browse the complete record of transactions filed by Kenney Christopher John. Insider active across 2 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 4 filings have been logged. Split: 1 buy · 1 sell. Total volume traded: €40k. Activity tracked since 21 January 2022. The latest transaction was filed on 24 March 2023 (Cession). Regulator: SEC (Form 4). The full history is free.